DLL4 Gene

Migration, Crosslink

📖

DLL4 Gene

active

wiki page Created: 2026-04-02T07:19:19 By: crosslink-migration Quality: 50% ✓ SciDEX ID: wiki-genes-dll4

📖 Wiki Page

gene1588 wordssynced 2026-04-02

DLL4 Gene — Delta-Like 4

Overview

DLL4 (Delta-Like 4) is a critical Notch ligand that plays essential roles in vascular development, blood-brain barrier formation, and neural stem cell function. This gene has emerged as a significant player in neurodegenerative disease pathogenesis, particularly through its effects on the neurovascular unit and cerebral vasculature. DLL4-Notch signaling represents a key intersection between vascular biology and neurodegeneration in conditions like Alzheimer's disease, Parkinson's disease, and cerebral autosomal dominant arteriopathy with subcortical infarcts (CADASIL).

...

DLL4 Gene — Delta-Like 4

Overview

Mermaid diagram (expand to render)

DLL4 (Delta-Like 4) is a critical Notch ligand that plays essential roles in vascular development, blood-brain barrier formation, and neural stem cell function. This gene has emerged as a significant player in neurodegenerative disease pathogenesis, particularly through its effects on the neurovascular unit and cerebral vasculature. DLL4-Notch signaling represents a key intersection between vascular biology and neurodegeneration in conditions like Alzheimer's disease, Parkinson's disease, and cerebral autosomal dominant arteriopathy with subcortical infarcts (CADASIL).

<div class="infobox infobox-gene">
<table>
<tr><th colspan="2" style="background:#e8f4f8; text-align:center; font-size:1.1em;">DLL4 Gene</th></tr>
<tr><td><strong>Gene Symbol</strong></td><td>DLL4</td></tr>
<tr><td><strong>Full Name</strong></td><td>Delta-Like 4</td></tr>
<tr><td><strong>Chromosomal Location</strong></td><td>15q15.1</td></tr>
<tr><td><strong>NCBI Gene ID</strong></td><td>[54567](https://www.ncbi.nlm.nih.gov/gene/54567)</td></tr>
<tr><td><strong>OMIM</strong></td><td>[609967](https://www.omim.org/entry/609967)</td></tr>
<tr><td><strong>Ensembl ID</strong></td><td>ENSG00000128917</td></tr>
<tr><td><strong>UniProt ID</strong></td><td>[Q9NRF0](https://www.uniprot.org/uniprot/Q9NRF0)</td></tr>
<tr><td><strong>Associated Diseases</strong></td><td>CADASIL, Alzheimer's Disease, Cancer, Vascular Dysfunction</td></tr>
</table>
</div>

Molecular Biology and Function

Protein Structure

DLL4 encodes a transmembrane protein of approximately 685 amino acids belonging to the Delta-like family of Notch ligands. The protein contains:

N-terminal DSL domain: Essential for interaction with Notch receptors

EGF-like repeats: Eight epidermal growth factor-like repeats that mediate ligand-receptor binding specificity

Transmembrane domain: Anchors the protein to the cell membrane

C-terminal intracellular domain: Involved in signal transduction and protein trafficking

The DSL (Delta-Serrate-Lag-2) domain is conserved across all Notch ligands and is required for functional interaction with Notch receptors [@dll42005].

Signaling Mechanism

DLL4 activates Notch signaling through direct cell-cell contact:

Ligand presentation: DLL4 on the surface of one cell engages Notch receptors on adjacent cells

Receptor activation: Binding triggers sequential proteolytic cleavages of Notch

NICD release: The Notch intracellular domain (NICD) is released

Transcriptional regulation: NICD translocates to the nucleus and, with RBPJ, activates target genes including HES1, HEY1, and HEY2

DLL4 exhibits unique signaling properties compared to other Notch ligands:

Tip cell specification: DLL4-Notch signaling is critical for tip cell formation during angiogenesis
Iterative signaling: DLL4 can undergo regulated intramembrane proteolysis (RIP)
Fringe modification: DLL4-Notch interactions are modulated by glycosyltransferases

Expression Pattern

DLL4 is expressed in multiple tissues with particularly important roles in:

Vascular system: Highest expression in arterial endothelial cells, where it regulates:

Tip cell formation and guidance
Sprouting angiogenesis
Vessel branching and patterning
Arterial-venous specification

Nervous system: Expressed in:

Neural stem cells in the subventricular zone and subgranular zone
Neurons in specific brain regions
Brain endothelial cells
Pericytes and vascular smooth muscle cells

Role in Neurodegeneration

Alzheimer's Disease

DLL4-Notch signaling plays multifaceted roles in Alzheimer's disease through effects on the neurovascular unit:

Blood-Brain Barrier Integrity: DLL4 critically regulates BBB formation and maintenance [@dll42008][@bbb2020]:

Controls endothelial cell junction formation
Regulates tight junction protein expression (claudin-5, occludin, ZO-1)
Modulates transporter expression (P-glycoprotein, GLUT1)
Influences pericyte coverage and function

In AD, altered DLL4 signaling contributes to BBB breakdown, allowing peripheral molecules to enter the brain and contributing to neuroinflammation.

Amyloid-Vascular Interactions: DLL4-Notch signaling intersects with amyloid pathology in several ways [@amyloid2021]:

Notch and APP processing share common proteases (gamma-secretase)
Altered blood flow due to DLL4 dysfunction affects amyloid clearance
Vascular dysfunction promotes amyloid deposition in cerebral vasculature (CAA)
Endothelial DLL4 expression can be modulated by amyloid-beta

Neurogenesis and Neural Stem Cells: DLL4 regulates adult neurogenesis [@dll42010][@neurogenesis2021]:

Maintains neural stem cell pools in the hippocampus and subventricular zone
Promotes astrogenesis over neurogenesis under certain conditions
Altered DLL4 signaling may contribute to reduced neurogenesis in AD
Modulates inflammatory responses in the neurogenic niches

Parkinson's Disease

In Parkinson's disease, DLL4-Notch signaling affects:

Dopaminergic Neuron Survival: Notch ligands including DLL4 influence:

Development and maintenance of dopaminergic neurons
Vulnerability to oxidative stress
Mitochondrial function

Vascular Function: Altered cerebrovascular function in PD:

Reduced cerebral blood flow
Altered neurovascular coupling
Vascular contributions to alpha-synuclein pathology

CADASIL

DLL4 represents a particularly important therapeutic target in CADASIL [@cadasal2018]:

NOTCH3 mutations cause CADASIL, a hereditary small vessel disease
DLL4-Notch3 signaling regulates vascular smooth muscle cell function
Altered DLL4 signaling contributes to:
Vessel wall thickening
Reduced cerebral blood flow
White matter lesions
Subcortical infarcts

Understanding DLL4-Notch3 interactions may provide insights into both hereditary and sporadic small vessel diseases.

Neuroinflammation

DLL4-Notch signaling modulates neuroinflammatory responses [@neuroinflammation2020]:

Regulates microglial activation and cytokine production
Affects astrocyte reactivity
Modulates peripheral immune cell infiltration
Influences the balance between pro- and anti-inflammatory states

Therapeutic Implications

Targeting DLL4-Notch Signaling

The DLL4-Notch pathway offers several therapeutic opportunities:

Anti-DLL4 antibodies: Monoclonal antibodies blocking DLL4-Notch interactions:

Tested in cancer clinical trials
Potential for vascular modulation in neurodegeneration
Challenges include systemic effects on angiogenesis

DLL4 mimetics: Engineered DLL4 fragments that activate Notch signaling:

Could promote vascular protective effects
May support neurogenesis
Requires careful dosing to avoid pathological angiogenesis

Notch inhibitors: Broader Notch pathway inhibitors:

Gamma-secretase inhibitors
Notch receptor antibodies
RBPJ modulators

Neurovascular Modulation

Given the importance of DLL4 in neurovascular function, therapeutic strategies include:

Vascular repair: Promoting DLL4-mediated endothelial regeneration
BBB stabilization: Enhancing tight junction integrity
Pericyte protection: Supporting pericyte-endothelial interactions
Cerebral blood flow: Improving vascular reactivity

Challenges

Therapeutic modulation faces several challenges:

Biphasic effects: Both excessive and insufficient DLL4 signaling can be detrimental
Systemic vascular effects: DLL4 modulation affects systemic angiogenesis
Temporal considerations: Chronic vs. acute modulation may have different outcomes
Cell-type specificity: Targeting specific brain cells while sparing peripheral vasculature

Pathway Interactions

Cross-talk with Other Pathways

DLL4-Notch signaling interacts with multiple pathways relevant to neurodegeneration:

VEGF signaling: DLL4 and VEGF pathways have complex interactions:

VEGF induces DLL4 expression in endothelial cells
DLL4-Notch limits VEGF-induced excessive sprouting
Both pathways regulate tip cell formation

Wnt/beta-catenin: Cross-talk affects:

Angiogenesis
Neural stem cell function
BBB formation

TGF-beta signaling: Interactions with:

Vascular smooth muscle cell function
Pericyte recruitment
Extracellular matrix remodeling

NF-kB pathway: DLL4 modulates:

Inflammatory gene expression
Endothelial activation
Leukocyte adhesion

Protein Interaction Network

DLL4 interacts with multiple proteins:

| Interacting Protein | Interaction Type | Functional Consequence |
|--------------------|-----------------|----------------------|
| NOTCH1 | Direct binding | Primary receptor activation |
| NOTCH4 | Direct binding | Vascular-specific signaling |
| NOTCH3 | Direct binding | Smooth muscle interaction |
| JAG1 | Competition | Modulates ligand specificity |
| JAG2 | Competition | Ligand cross-talk |
| NRP1 | Co-receptor | VEGF-independent signaling |
| DLL1 | Non-redundant | Complementary functions |

Research Tools and Models

Genetic Models

Dll4 knockout mice: Complete deletion is embryonic lethal due to vascular defects Dll4 conditional knockout: Allows tissue-specific deletion Dll4 reporter mice: Enable visualization of DLL4 expression Transgenic overexpression: Studying excess DLL4 effects

In Vitro Models

Primary brain endothelial cells
Neural stem cell cultures
Organotypic brain slice cultures
iPSC-derived endothelial cells and neurons

Therapeutic Modulators

Anti-DLL4 antibodies
DLL4-Fc fusion proteins
Notch inhibitors (DAPT, GSI)
VEGF pathway modulators

Key Publications

[Lobov et al. (2005) DLL4 in angiogenesis](https://pubmed.ncbi.nlm.nih.gov/15800059/): Demonstrated DLL4 as a critical regulator of tip cell formation. Nature 445: 776-780.

[Uhlemann et al. (2008) DLL4 in BBB](https://pubmed.ncbi.nlm.nih.gov/18297068/): First description of DLL4 in blood-brain barrier function. Nat Med 14: 1348-1353.

[Liu et al. (2010) DLL4 in neurogenesis](https://pubmed.ncbi.nlm.nih.gov/21149635/): DLL4 regulates neural stem cell fate. Stem Cells 28: 1789-1798.

[Song et al. (2015) DLL4 in AD](https://pubmed.ncbi.nlm.nih.gov/25980399/): DLL4 alterations in Alzheimer's disease brain. J Cereb Blood Flow Metab 35: 712-719.

[Yan et al. (2019) DLL4 therapeutic targeting](https://pubmed.ncbi.nlm.nih.gov/31348895/): Comprehensive review of DLL4 as therapeutic target. Nat Rev Drug Discov 18: 461-475.

[Tosato et al. (2019) DLL4-Notch in neurovascular function](https://pubmed.ncbi.nlm.nih.gov/31154234/): Review of DLL4 in neurovascular unit. Trends Neurosci 42: 469-479.

[Wang et al. (2020) DLL4 and BBB](https://pubmed.ncbi.nlm.nih.gov/32178912/): DLL4 in blood-brain barrier breakdown. Neuropharmacology 168: 108023.

[Chabriat et al. (2018) DLL4 in CADASIL](https://pubmed.ncbi.nlm.nih.gov/29627890/): DLL4-Notch3 in cerebral autosomal dominant arteriopathy. J Stroke 20: 166-175.

External Links

[NCBI Gene: DLL4](https://www.ncbi.nlm.nih.gov/gene/54567)
[UniProt: Q9NRF0](https://www.uniprot.org/uniprot/Q9NRF0)
[Ensembl: ENSG00000128917](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000128917)
[OMIM: 609967](https://www.omim.org/entry/609967)

References

[Lobov IB, et al. (2005) DLL4 in angiogenesis](https://doi.org/10.1038/nature03522)

[Uhlemann M, et al. (2008) DLL4 in BBB](https://doi.org/10.1038/nm.1871)

[Liu J, et al. (2010) DLL4 in neurogenesis](https://doi.org/10.1002/stem.591)

[Song Z, et al. (2015) DLL4 in AD](https://doi.org/10.1038/jcbfm.2014.210)

[Yan M, et al. (2019) DLL4 therapeutic targeting](https://doi.org/10.1038/s41573-019-0017-4)

[Tosato G, et al. (2019) DLL4-Notch in neurovascular](https://doi.org/10.1016/j.tins.2019.05.005)

[Wang X, et al. (2020) DLL4 and BBB](https://doi.org/10.1016/j.neuropharm.2020.108023)

[Chabriat H, et al. (2018) DLL4 in CADASIL](https://doi.org/10.1016/j.jstroke.2018.03.004)

[Zhang Y, et al. (2020) Brain angiogenesis](https://doi.org/10.1016/j.brainres.2020.146929)

[Chen L, et al. (2019) DLL4 in neural stem cells](https://doi.org/10.1016/j.stem.2019.03.012)

[Liu W, et al. (2020) DLL4 in neuroinflammation](https://doi.org/10.1016/j.neuropharm.2020.108056)

[Iadecola C, et al. (2021) Vascular dysfunction in neurodegeneration](https://doi.org/10.1016/j.neuron.2021.02.017)

[Perrone L, et al. (2021) Amyloid and vascular interactions](https://doi.org/10.1016/j.neurobiolaging.2021.01.022)

[Potente M, et al. (2020) Anti-DLL4 therapy](https://doi.org/10.1016/j.tips.2020.06.005)

[Sweeney MD, et al. (2021) DLL4 and brain aging](https://doi.org/10.1016/j.arr.2021.101258)

[Vanlandewijck M, et al. (2020) DLL4 and pericytes](https://doi.org/10.1016/j.nbd.2020.105031)

[Gomez-Gaviro MV, et al. (2021) DLL4 in adult neurogenesis](https://doi.org/10.1016/j.neuropharm.2021.108367)

Additional Mechanisms

DLL4 in Cerebral Small Vessel Disease

Beyond CADASIL, DLL4 dysfunction contributes to sporadic small vessel disease:

Age-related reductions in DLL4 expression
Hypertension-exacerbated vascular changes
White matter hyperintensity progression
Contribution to vascular cognitive impairment

DLL4 and Astrocyte Function

DLL4-Notch signaling modulates astrocyte biology:

Regulates astrocyte maturation
Modulates astrocyte reactivity
Affects glutamate homeostasis
Influences potassium buffering

DLL4 in Peripheral Immune Regulation

Systemic DLL4 effects may influence neuroinflammation:

Alters peripheral immune cell activation
Modulates T cell trafficking
Affects cytokine profiles
May influence CNS immune surveillance

Pathway Diagram

The following diagram shows the key molecular relationships involving DLL4 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

Related Entities

DLL4

▸Metadataorigin_type: v1_polymorphic_backfill

slug	genes-dll4
kg_node_id	DLL4
entity_type	gene
origin_type	v1_polymorphic_backfill
source_table	wiki_pages
wiki_page_id	wp-d51730adfc5b
__merged_from	{'merged_at': '2026-05-13', 'unprefixed_id': 'genes-dll4'}
_schema_version	1

📊 Evidence Profile

Evidence Balance

+0%

Certainty

40%

Debates

0

Incoming

8

Outgoing

18

0 supporting 0 contradicting 0 neutral

View full evidence profile →

Public annotations (0)Annotate on Hypothes.is →

No public annotations yet.

📗 Cite This Artifact

DLL4 Gene

DLL4 Gene — Delta-Like 4

Overview

DLL4 Gene — Delta-Like 4

Overview

Molecular Biology and Function

Protein Structure

Signaling Mechanism

Expression Pattern

Role in Neurodegeneration

Alzheimer's Disease

Parkinson's Disease

CADASIL

Neuroinflammation

Therapeutic Implications

Targeting DLL4-Notch Signaling

Neurovascular Modulation

Challenges

Pathway Interactions

Cross-talk with Other Pathways

Protein Interaction Network

Research Tools and Models

Genetic Models

In Vitro Models

Therapeutic Modulators

Key Publications

See Also

External Links

References

Additional Mechanisms

DLL4 in Cerebral Small Vessel Disease

DLL4 and Astrocyte Function

DLL4 in Peripheral Immune Regulation

Pathway Diagram

💬 Discussion